About

My work currently focuses on means of measuring and enhancing immune responses to HIV-infected cells as they emerge from latency in individuals who have been maintained on suppressive ART. Additionally, my focus in the laboratory has been on the development and optimization of a novel latency clearance assay as a means of evaluating the ability of various immunotherapeutics to clear latent HIV infection. This assay serves as both a tool to evaluate the therapeutic potential of various agents, as well as a mechanism for probing the kinetics of HIV latency reversal. My particular interest is in optimizing and standardizing assays to detect such an enhancement, and elucidating the mechanisms underlying an effective anti-latency immune response.